ICP incidence at nearly 3% worldwide, but varies by region: Study
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Health Canada has authorized a point-of-care test that may be used to quickly diagnose hepatitis C and monitor treatment response.| Liver Disease News
